Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>The Clorox Company's third-quarter financial results suggest a continuing recovery from the August cyberattack that affected its operations.</li><li>Despite lower sales and significant investments in its brands, the company's adjusted earnings per share exceeded its own expectations in the said quarter.</li><li>Adjusting for the effects of the cyberattack, the company reported that Q3 sales performance was, for the most part, in line with the management's expectations.</li></ul>

The Clorox Company's third-quarter financial results suggest a continuing recovery from the August cyberattack that affected its operations.Despite lower sales and significant investments in its brands, the company's adjusted earnings per share exceeded its own expectations in the said quarter.Adjusting for the effects of the cyberattack, the company reported that Q3 sales performance was, for the most part, in line with the management's expectations.

The Clorox Company: A Story Of Innovation-Led Growth

<ul><li>The Clorox Company delivered second-quarter financial results for 2024 that exceeded expectations, driven largely by a strong recovery from a cyber attack that occurred in August.</li><li>The company preserved its strong brand superiority by advancing its strategies to drive top line growth and rebuild margins, as well as actively managing currency headwinds in Argentina.</li><li>Retailer inventories are being refreshed more quickly than anticipated, which is aiding the restoration of distribution and improvement of market shares.</li></ul>

The Clorox Company delivered second-quarter financial results for 2024 that exceeded expectations, driven largely by a strong recovery from a cyber attack that occurred in August.The company preserved its strong brand superiority by advancing its strategies to drive top line growth and rebuild margins, as well as actively managing currency headwinds in Argentina.Retailer inventories are being refreshed more quickly than anticipated, which is aiding the restoration of distribution and improvement of market shares.

The Clorox Company: A Genius Strategy to Crush Digital Transformation and Improve Sales! - Major Drivers

<ul><li>The Clorox Company managed to exceed the revenue expectations as well as the earnings expectations of Wall Street.</li><li>Clorox's performance aligned with expectations preceding the cyber-attack in August, showcasing strong consumption and market share trends.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

The Clorox Company managed to exceed the revenue expectations as well as the earnings expectations of Wall Street.Clorox's performance aligned with expectations preceding the cyber-attack in August, showcasing strong consumption and market share trends.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

The Clorox Company: Managing Supply Chain Inflation and Gross Margins! - Major Drivers

<ul><li>The Clorox Company managed to exceed analyst expectations in terms of revenue and earnings.</li><li>Strong results at the quarter's end highlight the tremendous progress the company has made with its strategic priorities.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

The Clorox Company managed to exceed analyst expectations in terms of revenue and earnings.Strong results at the quarter's end highlight the tremendous progress the company has made with its strategic priorities.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

The Clorox Company: Unmasking Their Strategy to Restore Pre-Pandemic Margins! - Major Drivers

<ul><li>Despite a difficult operational and cost environment, Clorox produced solid results in the third quarter, managing an all-around beat, with organic sales growth in each of its 4 businesses, an increase in gross margin, and double-digit adjusted EPS growth.</li><li>Clorox made excellent strides throughout the quarter by increasing margin while sustaining top-line growth.</li><li>Clorox also experienced an increase in gross margin, helped by cost-justified pricing and cost reductions that reached a decade-high level.</li></ul>

Despite a difficult operational and cost environment, Clorox produced solid results in the third quarter, managing an all-around beat, with organic sales growth in each of its 4 businesses, an increase in gross margin, and double-digit adjusted EPS growth.Clorox made excellent strides throughout the quarter by increasing margin while sustaining top-line growth.Clorox also experienced an increase in gross margin, helped by cost-justified pricing and cost reductions that reached a decade-high level.

The Clorox Company: Launch of Start Clean & Other Developments

United States

The Clorox Company produces and markets non-durable consumer products sold primarily through grocery and other retail stores.  The Company's principal products include household cleaning and bleach products, charcoal, cat litter, automotive care products, dressings, and trash bags.  Clorox markets its products in the United States and other countries around the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Clorox Company (CLX US)

The Clorox Company: A Story Of Innovation-Led Growth

The Clorox Company's third-quarter financial results suggest a continuing recovery from the August cyberattack that affected its...

Baptista Research

The Clorox Company: A Genius Strategy to Crush Digital Transformation and Improve Sales! - Major Drivers

The Clorox Company delivered second-quarter financial results for 2024 that exceeded expectations, driven largely by a strong recovery from a...

Baptista Research

The Clorox Company: Managing Supply Chain Inflation and Gross Margins! - Major Drivers

The Clorox Company managed to exceed the revenue expectations as well as the earnings expectations of Wall Street. Clorox's performance aligned...

Baptista Research

The Clorox Company: Unmasking Their Strategy to Restore Pre-Pandemic Margins! - Major Drivers

The Clorox Company managed to exceed analyst expectations in terms of revenue and earnings. Strong results at the quarter's end highlight the...

Baptista Research

The Clorox Company: Launch of Start Clean & Other Developments

Despite a difficult operational and cost environment, Clorox produced solid results in the third quarter, managing an all-around beat, with...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)